U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07390643) titled 'The DISCOVER Study' on Jan. 26.

Brief Summary: The purpose of this research study is to evaluate the possible benefits of screening with an investigational, but commercially available blood test designed to detect many types of cancer.

The name of the screening blood test being studied is:

-GRAIL Galleri MCED test

Study Start Date: July, 2026

Study Type: INTERVENTIONAL

Condition: Cancer Cancer Diagnosis

Intervention: DEVICE: GRAIL Galleri MCED test

A multi-cancer early detection (MCED) blood test.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Dana-Farber Cancer Institute

Information provided by (Responsible Party): Eliz...